Defective death receptor signaling as a cause of tumor immune escape

Seminars in Cancer Biology

Volumn 12, Issue 1, 2002, Pages 51-55

  French, Lars E ^a   Tschopp, Jürg ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Apoptosis; Cytolysis; Death receptors; Fas; FLIP

Indexed keywords

CASPASE 8; CELL RECEPTOR; DEATH RECEPTOR; FAS LIGAND; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CYTOLYSIS; ENZYME ACTIVATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; NONHUMAN; PROTEIN FAMILY; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR ESCAPE;

EID: 0036155773     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.2001.0405     Document Type: Article

References (34)

1. Death receptors: Signaling and modulation
2. Apoptosis control by death and decoy receptors
3. Apoptosis by death factor
4. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
5. Inhibition of death receptor signals by cellular FLIP
6. Inhibition of Fas death signals by FLIPs
7. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
8. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma
9. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
10. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
11. Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for FAS- but not perforin-dependent cytotoxicity or cytokine production
12. Melanoma cell expression of Fas (Apo1/CD95) ligand: Implications for tumor immune escape
13. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
14. Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma
15. Apoptosis, Fas and Fas-ligand expression in melanocytic tumors
16. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells
17. Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bclx expression and is sensitive to modulation by interferon-gamma
18. Fas and Fas ligand interactions suppress melanoma lung metastasis
19. Ras mutations in human melanoma: A marker of malignant progression
20. Analysis of ras mutations in human melanocytic lesions: Activation of the ras gene seems to be associated with the nodular type of human malignant melanoma
21. Pas gene mutations: A rare event in nonmetastatic primary malignant melanoma
22. Essential role for oncogenic Ras in tumor maintenance
23. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras
24. Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas
25. Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity
26. Fas gene mutation in the progression of adult T cell leukemia
27. The Fas counterattack: Cancer as a site of immune privilege
28. Gene transfer of Fas ligand induces tumor regression in vivo
29. Human melanoma cells do not express Fas (Apo-1/CD95) ligand
30. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: Selective rescue by caspase inhibition
31. Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection
32. Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL)
33. Regulation of the proinflammatory effects of Fas ligand (CD95L)
34. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction. A new role for fas ligand in inflammatory responses